{"first_name":"Abbie","last_name":"Celniker","permalink":"abbie-celniker","crunchbase_url":"http://www.crunchbase.com/person/abbie-celniker","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Mon Jun 22 07:35:03 UTC 2009","updated_at":"Mon Jun 22 07:35:34 UTC 2009","overview":"<p>Dr. Celniker has more than 20 years of experience in building biologics-focused businesses. Prior to joining Taligen, Dr. Celniker was global head of Novartis Biologics at Novartis. In this role she built and managed the basic infrastructure and strategy for the late-stage discovery and development of protein therapeutics at Novartis. Previously, she held senior research and development position leadership roles with Millenium Pharmaceuticals, Wyeth BioPharma (Genetics Institute) and Genentech. Dr. Celniker holds a Ph.D. in molecular biology from the University of Arizona and a B.A. in biology from the University of California, San Diego.</p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"CEO","firm":{"name":"Taligen Therapeutics","permalink":"taligen-therapeutics","type_of_entity":"company","image":{"available_sizes":[[[130,59],"assets/images/resized/0005/0041/50041v1-max-150x150.png"],[[130,59],"assets/images/resized/0005/0041/50041v1-max-250x250.png"],[[130,59],"assets/images/resized/0005/0041/50041v1-max-450x450.png"]],"attribution":null}}},{"is_past":false,"title":"CEO","firm":{"name":"Eleven Biotherapeutics","permalink":"eleven-biotherapeutics","type_of_entity":"company","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/9609/79609v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0007/9609/79609v1-max-250x250.jpg"],[[360,85],"assets/images/resized/0007/9609/79609v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}